Zobrazeno 1 - 10
of 41
pro vyhledávání: '"MaryTere Herrera"'
Autor:
Berenice Carbajal-López, Jossimar Coronel-Hernández, Marytere Herrera, Erika Ruiz-Garcia, Sayako M. Miyagui-Adame, Consuelo Diaz-Romero, Eduardo Osiris Madrigal-Santillán, Priscila Morales Esponda-Mendoza, Carlos Pérez-Plasencia, Germán Calderillo-Ruiz
Publikováno v:
Diagnostics, Vol 14, Iss 22, p 2550 (2024)
Background: The diagnosis of colorectal cancer (CRC) at early ages has become a challenging trend for oncology due to high rates of mortality worldwide. The correlation of clinical features with young-age prognosis in CRC remains unclear. Therefore,
Externí odkaz:
https://doaj.org/article/b65f8edf64f0420ba6fe1ab9771ba426
Autor:
Wendy R. Muñoz-Montaño, Horacio N. López-Basave, Alison Castillo-Morales, Carolina Castillo-Morales, Karen Sánchez-Trejo, Rodrigo Catalán, Consuelo Díaz-Romero, Leonardo S. Lino-Silva, Andrea Maliachi-Díaz, Erika Ruiz-García, Marytere Herrera-Martínez, German Calderillo-Ruíz
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-13 (2023)
Abstract Background Interindividual survival and recurrence rates in cases of locoregional colon cancer following surgical resection are highly variable. The aim of the present study was to determine whether elevated pre-operative and post-operative
Externí odkaz:
https://doaj.org/article/bbbfde370cbf414897c2a473474f9538
Publikováno v:
Bioethics Update, Vol 10, Iss 1 (2024)
Antecedentes: Los progresos en oncología han permitido disponer de una gran cantidad de intervenciones novedosas, pero en diversas ocasiones no existe certeza sobre los resultados; al no existir una única decisión, es necesario incorporar en la to
Externí odkaz:
https://doaj.org/article/8dffaed272b24c42a6f418124a2dc72e
Autor:
Germán Calderillo-Ruiz, Laura Torrecillas-Torres, Alejandro Silva, Erika Ruiz-García, Alberto Pimentel-Rentería, Carlos Hernández-Hernández, Tirzo Suárez-Sahui, Isabel Enríquez-Aceves, Saúl Campos-Gómez, Marytere Herrera, Karim Dip, Consuelo Díaz-Romero
Publikováno v:
Gaceta Mexicana de Oncología, Vol 20, Iss 4 (2021)
Background: First and second line standard treatment in patients with metastatic colorectal cancer (mCRC) is with chemotherapy +/- some monoclonal antibody according to the RAS biomarker report. About 30-40% of them will require a third line of thera
Externí odkaz:
https://doaj.org/article/0ef558e841114da69206797d71295c4d
Autor:
German Calderillo Ruiz, Horacio Lopez Basave, Rafael Sebastian Vazquez Renteria, Alison Castillo Morales, Alberto Guijosa, Carolina Castillo Morales, Marytere Herrera, Consuelo Diaz, Ezequiel Vazquez Cortes, Erika Ruiz-Garcia, Wendy R. Munoz Montano
Publikováno v:
Journal of Oncology. 2022:1-11
Background. Survival and recurrence rates following locoregional colon cancer surgical resection are highly variable. Currently used tools to assess patient risk are still imperfect. In the present work, we evaluate, for the first time, the prognosti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86b42777686703b96b965734e6e64607
https://doi.org/10.1155/2022/4324635
https://doi.org/10.1155/2022/4324635
Autor:
Wendy R. Muñoz-Montaño, Horacio López-Basave, Karen Sánchez-Trejo, Rodrigo Catalán Sandoval, Consuelo Díaz-Romero, Leonardo Lino-Silva, Andrea Maliachi Diaz, Erika Ruiz-García, Marytere Herrera-Martínez, Germán Calderillo-Ruiz, Carolina Castillo-Morales, Alison Castillo-Morales
Background: In locoregional colon cancer, interindividual survival and recurrence rates following surgical resection are highly variable. The aim of the present study was to determine whether elevated preoperative and postoperative CEA values are use
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::58cd977657a60126b1ccfb93cd85788f
https://doi.org/10.21203/rs.3.rs-2139471/v1
https://doi.org/10.21203/rs.3.rs-2139471/v1
Autor:
Alejandro González-Garay, Marco Antonio Figueroa-Morales, Gibert Maza Ramos, Zuratzi Deneken-Hernandez, Juan Alberto Tenorio-Torres, Manuel Ernesto Magallanes-Maciel, Francisco Lozano-Ruiz, Yolanda Bautista-Aragón, Nathaly García-Orozco, Ricardo Villalobos, Brenda Carbajal-Saldaña, Liliana Velasco Hidalgo, María de la Luz García-Tinoco, José Luis Mayorga-Butrón, Marta Zapata Tarrés, Rubí Ramos-Prudencio, Miguel Ángel Pluma-Jiménez, Federico Maldonado-Magos, Daniel Rivera-Sánchez, Marytere Herrera-Martínez, Samuel Rivera-Rivera, Carlos Domínguez-Reyes, Luis Alfonso Romero-Robles, Antonio Maffuz-Aziz, Jorge Alberto Guadarrama-Orozco, Yanin Chavarri-Guerra, Gregorio Quintero-Beuló, Fabiola Flores-Vázquez, Juan Enrique Bargallo-Rocha, Francisco Javier Ochoa-Carrillo, Bertha Beatriz Montaño Velázquez, Rocío Grajales-Álvarez, Jaime Alonzo Reséndiz Colosia, Mónica Blake-Cerda, Betsabé Hernández-Hernández, Claudia Arce-Salinas, Marco Rodrigo Aguilar Ortíz, Felipe Villegas-Carlos, Georgina Garnica-Jaliffe, Raymundo Hernández-Montes de Oca, Cynthia Villarreal-Garza
Publikováno v:
Gaceta Mexicana de Oncolog�a. 17
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f116182bc7b4bfa8a9d4da5db785be03
https://doi.org/10.24875/j.gamo.m18000161
https://doi.org/10.24875/j.gamo.m18000161
Autor:
Alberto Mitsuo Leon Takahashi, Horacio Noe Lopez Basave, Leonardo Saul Lino Silva, German Calderillo Ruiz, Erika Betzabe Ruiz Garcia, Maria del Consuelo Diaz Romero, Marytere Herrera Martinez, Cesar Alejandro Paleta Torres, Karla Fabiola Hernandez Castañeda, Angel Herrera Gomez
Publikováno v:
Diseases of the Esophagus. 35
In 2020, the incidence of esophageal cancer was 8th and mortality was 6th in the world. However, it´s not the top 10 in Mexico. Mexico is a developing country and has no national cancer registration. Moreover, Mexico is the 2nd largest obese country
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fffc3a64f6d477093b562e5b919bb7ec
https://doi.org/10.1093/dote/doac051.538
https://doi.org/10.1093/dote/doac051.538
Autor:
Marytere Herrera, Andrea Maliachi Diaz, Consuelo Diaz, Veronica Salais Michaus, Erika Ruiz, Sebastian Garcia, Sayako Miyagui Adame, German Calderillo Ruiz
Publikováno v:
Journal of Clinical Oncology. 41:683-683
683 Background: Effectiveness of FOLFIRINOX and Gemcitabine – Nabpaclitaxel as first-line chemotherapy regimens in advanced pancreatic cancer has been demonstrated in phase III clinical trials. However, prospective studies directly comparing both i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8b7cfccba14d521e43a34ea723b6ec9a
https://doi.org/10.1200/jco.2023.41.4_suppl.683
https://doi.org/10.1200/jco.2023.41.4_suppl.683
Autor:
Maria del Consuelo Diaz Romero, Stefan Zilli Hernandez, German Calderillo Ruiz, Ana Zyanya Xcaret Camacho Sanchez, Berenice Carbajal, Marytere Herrera, Erika Ruiz-Garcia, Sayako Mariana Miyagui-Adame
Publikováno v:
Journal of Clinical Oncology. 41:517-517
517 Background: Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related death worldwide. The assessment of liver function is crucial in determining the prognosis of patients. Aim: To compare the utility of the ALBI and CHILD-PUG
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2d8da3a840bee649b244041171969a75
https://doi.org/10.1200/jco.2023.41.4_suppl.517
https://doi.org/10.1200/jco.2023.41.4_suppl.517